774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma

Gino K In; Sunandana Chandra; Jeffrey Sosman; Erin Barrett; Ashley Wysong; Alissa Marr; Joshua Mammen; Jacob Thomas; Thomas Won; Anisa Sandin; Sophia Marmolejo; Andrew Zeng; Fumito Ito; Niels Kokot; Mark Swanson; Daniel Kwon; Denice Tsao-Wei; Susan Groshen; Kevin Kelly; Hugo Lara Martinez; Andy Sherrod; Brittney Declerck; Gene Kim; David Peng; Jenny C Hu

doi:10.1136/jitc-2023-SITC2023.0774

Article info

Regular and Young Investigator Award Abstracts

Clinical Trial In Progress

774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma

Authors

Gino K In University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Sunandana Chandra Northwestern University, Chicago, IL, USA PubMed articles Google scholar articles
Jeffrey Sosman Northwestern University, Chicago, IL, USA PubMed articles Google scholar articles
Erin Barrett University of Nebraska Medical Center, Omaha, NE, USA PubMed articles Google scholar articles
Ashley Wysong University of Nebraska Medical Center, Omaha, NE, USA PubMed articles Google scholar articles
Alissa Marr University of Nebraska Medical Center, Omaha, NE, USA PubMed articles Google scholar articles
Joshua Mammen University of Nebraska Medical Center, Omaha, NE, USA PubMed articles Google scholar articles
Jacob Thomas University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Thomas Won University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Anisa Sandin University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Sophia Marmolejo University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Andrew Zeng University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Fumito Ito Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA PubMed articles Google scholar articles
Niels Kokot University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles
Mark Swanson University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles
Daniel Kwon University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles
Denice Tsao-Wei University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA University of Southern California, Los Angeles, CA, USA PubMed articles Google scholar articles
Susan Groshen University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Kevin Kelly University of Southern California, Los Angeles, CA, USA PubMed articles Google scholar articles
Hugo Lara Martinez University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA PubMed articles Google scholar articles
Andy Sherrod University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles
Brittney Declerck University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles
Gene Kim University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles
David Peng University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles
Jenny C Hu University of Southern California, Keck School of Medicine, Los Angeles, CA, USA PubMed articles Google scholar articles

Citation

In GK, Chandra S, Sosman J, et al

774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma

Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0774

Online issue publication

November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password